Edition:
United States

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

12.35USD
12 Dec 2017
Change (% chg)

$-0.15 (-1.20%)
Prev Close
$12.50
Open
$12.45
Day's High
$12.55
Day's Low
$12.35
Volume
4,214
Avg. Vol
15,844
52-wk High
$13.95
52-wk Low
$6.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.095
Jun '17 0.00 -1.332
Mar '17 0.00 -1.344
FY 2016 Dec '16 0.00 -1.525
Sep '16 0.00 -1.492
Jun '16 0.00 -1.867
Mar '16 0.00 -10.418
FY 2015 Dec '15 0.00 -25.782
Sep '15 0.00 -14.704
Jun '15 0.00 -13.335
Mar '15 0.00 -4.148
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 3.33 16.67 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 3 -1.07 -0.98 -1.15 -1.27
Quarter Ending Mar-18 2 -1.11 -1.08 -1.14 --
Year Ending Dec-17 3 -4.82 -4.74 -4.87 -4.96
Year Ending Dec-18 5 -4.54 -3.63 -5.28 -4.53
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.97 35.27
P/E High - Last 5 Yrs. -- 274.53 45.26
P/E Low - Last 5 Yrs. -- 92.51 24.18
Beta 2.52 0.83 0.91
Price to Sales (TTM) -- 114.29 5.83
Price to Book (MRQ) 10.47 22.17 5.62
Price to Tangible Book (MRQ) 10.47 25.97 7.22
Price to Cash Flow (TTM) -- 101.40 24.19
% Owned Institutions 54.43 5.64 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.04
Dividend 5 Year Growth Rate -- 1.96 5.26
Payout Ratio(TTM) -- 96.00 46.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.18 6.84
Sales (TTM) vs TTM 1 Yr. Ago -- 30.07 5.66
Sales - 5 Yr. Growth Rate -- 33.24 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.57 -149.23 7.22
EPS (TTM) vs TTM 1 Yr. Ago 86.61 -- --
EPS - 5 Yr. Growth Rate -- 43.30 10.92
Capital Spending - 5 Yr. Growth Rate -- 40.86 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 5.78 5.74 3.56
LT Debt to Equity (MRQ) 119.42 14.43 13.40
Total Debt to Equity (MRQ) 119.42 16.88 19.46
Interest Coverage (TTM) -38.57 -147.14 44.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.80 54.92
Gross Margin - 5 Yr. Avg. -- 55.48 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -218.62 15.49
Operating Margin (TTM) -- -632.11 6.65
Operating Margin - 5 Yr. Avg. -- -235.48 10.97
Pre-Tax Margin (TTM) -- -603.10 7.47
Pre-Tax Margin - 5 Yr. Avg. -- -235.80 11.38
Net Profit Margin (TTM) -- -600.62 3.70
Net Profit Margin - 5 Yr. Avg. -- -239.05 7.67
Effective Tax Rate (TTM) -- 15.26 24.26
Effective Tax Rate - 5 Yr. Avg. -- 18.70 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,614,065 848,695,288
Net Income/Employee (TTM) -2,216,150 -1,754,114 99,009,570
Receivable Turnover (TTM) -- 25.64 6.11
Inventory Turnover (TTM) -- 2.61 3.55
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.73 -9.38 11.28
Return on Assets - 5 Yr. Avg. -53.65 0.11 12.25
Return on Investment (TTM) -111.33 -11.84 14.40
Return on Investment - 5 Yr. Avg. -67.98 3.18 16.04
Return on Equity (TTM) -137.18 -36.93 15.99
Return on Equity - 5 Yr. Avg. -- 5.57 17.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 87.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eiger BioPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.43%
# of Holders: 57
Total Shares Held: 6,775,630
3 Mo. Net Change: 1,051,024
# New Positions: 10
# Closed Positions: 17
# Increased Positions: 19
# Reduced Positions: 24
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.